Cargando…
SAT-580 Tocilizumab Improvement in a Patient with Corticosteroid Resistant Thyroid Orbitopathy: Report of a Case
Thyroid orbithopathy is an autoimmune disorder being the most frequent extrathyroideal manifestation. It can present before or even years after hyperthyroidism, although occasionally in nonhyperthyroid patients. The severe form has been described in 5% of the presentations. Treatment begins with smo...
Autores principales: | Coy, Andres, Sanchez, Pedro, Rojas, William, Sierra Osorio, Ariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552220/ http://dx.doi.org/10.1210/js.2019-SAT-580 |
Ejemplares similares
-
A case of Tocilizumab-induced thrombocytopenia in steroid-resistant Graves orbitopathy
por: Cuculescu, Victoria, et al.
Publicado: (2023) -
SAT-582 Autoimmune Hepatitis Presenting with Graves Disease
por: Coy, Andres, et al.
Publicado: (2019) -
SAT-500 Response to Tocilizumab Retreatment in Refractory Thyroid Eye Disease
por: Kaplan, Daniel, et al.
Publicado: (2020) -
SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019) -
SAT-429 Systemic Safety Analysis of Mycophenolate in Graves’ Orbitopathy
por: Lee, Alan C H, et al.
Publicado: (2020)